Cantargia
1 known investors
Find your way into Cantargia
Each arrow is one introduction. Sign up to fill in the first one.
86 people can intro you to Hilde
Ask Maha Katabi to introduce you to Hilde H. Steineger
You →Maha · together at Northsea Therapeutics →Hilde
Sign up to find every way you can get introduced to Cantargia
- Your email: who you already know at Cantargia, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Cantargia team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Cantargia is a company listed on Nasdaq Stockholm (Small Cap). The page presents shareholder and stock information, including its largest owners.
Founders & leadership
HH

Hilde H. SteinegerHilde H. Steineger holds a PhD in medical biochemistry from the University of Oslo and an M.Sc. in molecular biology/biotechnology. She has held CEO positions at Cantargia (an oncology company) and Staten Biotechnology, co-founded and served as COO of NorthSea Therapeutics, and spent six years as Vice President of Business Development at Pronova BioPharma; she has also held leadership roles at BASF in innovation management and worked as a financial analyst and venture capitalist focused on life sciences.
Investors · 1
Sunstone Capitallisted by Sunstone CapitalFrederiksberg
How we know: Sunstone Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Cantargia do?
- Cantargia is a company listed on Nasdaq Stockholm (Small Cap). The page presents shareholder and stock information, including its largest owners.
- Who are Cantargia's investors?
- Cantargia's investors include Sunstone Capital.

